The serum levels of gasdermin D in uremic patients and its relationship with the prognosis: a prospective observational cohort study

References

• Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:1–8. doi:10.1007/978-981-13-8871-2_1.
   Google Scholar
• Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7–11. doi:10.1016/j.kisu.2021.11.003.
   PubMed Web of Science ®Google Scholar
• Jankowski J, Floege J, Fliser D, et al. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157–1172. doi:10.1161/CIRCULATIONAHA.120.050686.
   PubMed Web of Science ®Google Scholar
• Hu EA, Steffen LM, Grams ME, et al. Dietary patterns and risk of incident chronic kidney disease: the atherosclerosis risk in communities study. Am J Clin Nutr. 2019;110(3):713–721. doi:10.1093/ajcn/nqz146.
   PubMed Web of Science ®Google Scholar
• Jun JE, Lee Y-B, Lee S-E, et al. Elevated serum uric acid predicts the development of moderate coronary artery calcification independent of conventional cardiovascular risk factors. Atherosclerosis. 2018;272:233–239. doi:10.1016/j.atherosclerosis.2018.02.014.
   PubMed Web of Science ®Google Scholar
• Ejaz AA, Nakagawa T, Kanbay M, et al. Hyperuricemia in kidney disease: a major risk factor for cardiovascular events, vascular calcification, and renal damage. Semin Nephrol. 2020;40(6):574–585. doi:10.1016/j.semnephrol.2020.12.004.
   PubMed Web of Science ®Google Scholar
• Choi SR, Lee Y-K, Cho AJ, et al. Malnutrition, inflammation, progression of vascular calcification and survival: inter-relationships in hemodialysis patients. PLoS One. 2019;14(5):e0216415. doi:10.1371/journal.pone.0216415.
   PubMed Web of Science ®Google Scholar
• Yu P, Zhang X, Liu N, et al. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6(1):128. doi:10.1038/s41392-021-00507-5.
   PubMed Web of Science ®Google Scholar
• Zeng C, Wang R, Tan H. Role of pyroptosis in cardiovascular diseases and its therapeutic implications. Int J Biol Sci. 2019;15(7):1345–1357. doi:10.7150/ijbs.33568.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wu J, Zeng Y, et al. Pyroptosis: a pro-inflammatory type of cell death in cardiovascular disease. Clin Chim Acta. 2020;510:62–72. doi:10.1016/j.cca.2020.06.044.
   PubMed Web of Science ®Google Scholar
• Xu Y-J, Zheng L, Hu Y-W, et al. Pyroptosis and its relationship to atherosclerosis. Clin Chim Acta. 2018;476:28–37. doi:10.1016/j.cca.2017.11.005.
   PubMed Web of Science ®Google Scholar
• Liu W, Shen J, Li Y, et al. Pyroptosis inhibition improves the symptom of acute myocardial infarction. Cell Death Dis. 2021;12(10):852. doi:10.1038/s41419-021-04143-3.
   PubMed Web of Science ®Google Scholar
• Toldo S, Mauro AG, Cutter Z, et al. Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2018;315(6):H1553–H1568. doi:10.1152/ajpheart.00158.2018.
   PubMed Web of Science ®Google Scholar
• Habimana O, Salami OM, Peng J, et al. Therapeutic implications of targeting pyroptosis in cardiac-related etiology of heart failure. Biochem Pharmacol. 2022;204:115235. doi:10.1016/j.bcp.2022.115235.
   PubMed Web of Science ®Google Scholar
• Pang Q, Wang P, Pan Y, et al. Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease. Cell Death Dis. 2022;13(3):283. doi:10.1038/s41419-022-04735-7.
   PubMed Web of Science ®Google Scholar
• Burdette BE, Esparza AN, Zhu H, et al. Gasdermin D in pyroptosis. Acta Pharm Sin B. 2021;11(9):2768–2782. doi:10.1016/j.apsb.2021.02.006.
   PubMed Web of Science ®Google Scholar
• Tonnus W, Maremonti F, Belavgeni A, et al. Gasdermin D-deficient mice are hypersensitive to acute kidney injury. Cell Death Dis. 2022;13(9):792. doi:10.1038/s41419-022-05230-9.
   PubMed Web of Science ®Google Scholar
• Fang Z, Wu G, Sheng J, et al. Gasdermin D affects aortic vascular smooth muscle cell pyroptosis and ang II-induced vascular remodeling. Heliyon. 2023;9(6):e16619. doi:10.1016/j.heliyon.2023.e16619.
   PubMed Web of Science ®Google Scholar
• Cui R-R, Mao D-A, Yi L, et al. Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/akt signaling pathways. Amino Acids. 2010;39(5):1193–1200. doi:10.1007/s00726-010-0555-x.
   PubMed Web of Science ®Google Scholar
• Peeters MJ, van den Brand JAJG, van Zuilen AD, et al. Abdominal aortic calcification in patients with CKD. J Nephrol. 2017;30(1):109–118. doi:10.1007/s40620-015-0260-7.
   PubMed Web of Science ®Google Scholar
• Elmasri K, Hicks Y, Yang X, et al. Automatic detection and quantification of abdominal aortic calcification in dual energy X-ray absorptiometry. Proc Comput Sci. 2016;96:1011–1021. doi:10.1016/j.procs.2016.08.116.
   Google Scholar
• Bosco E, Hsueh L, McConeghy KW, et al. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021;21(1):241. doi:10.1186/s12874-021-01440-5.
   PubMed Web of Science ®Google Scholar
• Modi ZJ, Lu Y, Ji N, et al. Risk of cardiovascular disease and mortality in young adults with end-stage renal disease: an analysis of the US renal data system. JAMA Cardiol. 2019;4(4):353–362. doi:10.1001/jamacardio.2019.0375.
   PubMed Web of Science ®Google Scholar
• Chen H-C, Wang W-T, Hsi C-N, et al. Abdominal aortic calcification score can predict future coronary artery disease in hemodialysis patients: a 5-year prospective cohort study. BMC Nephrol. 2018;19(1):313. doi:10.1186/s12882-018-1124-x.
   PubMedGoogle Scholar
• Lee SM, Kim SE, Lee JY, et al. Serum myostatin levels are associated with abdominal aortic calcification in dialysis patients. Kidney Res Clin Pract. 2019;38(4):481–489. doi:10.23876/j.krcp.19.019.
   PubMed Web of Science ®Google Scholar
• Ito M, Yamaguchi M, Katsuno T, et al. Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5. PLoS One. 2021;16(6):e0253592. doi:10.1371/journal.pone.0253592.
   PubMed Web of Science ®Google Scholar
• Eelderink C, Te Velde-Keyzer CA, Frenay AS, et al. Serum calcification propensity and the risk of cardiovascular and all-Cause mortality in the general population: the PREVEND study. Arterioscler Thromb Vasc Biol. 2020;40(8):1942–1951. doi:10.1161/atvbaha.120.314187.
   PubMed Web of Science ®Google Scholar
• Ter Braake AD, Govers LP, Peeters MJ, et al. Low plasma magnesium concentration and future abdominal aortic calcifications in moderate chronic kidney disease. BMC Nephrol. 2021;22(1):71. doi:10.1186/s12882-021-02267-4.
   PubMed Web of Science ®Google Scholar
• Ter Braake AD, Vervloet MG, de Baaij JHF, et al. Magnesium to prevent kidney disease-associated vascular calcification: crystal clear? Nephrol Dial Transplant. 2022;37(3):421–429. Feb 25 doi:10.1093/ndt/gfaa222.
   PubMed Web of Science ®Google Scholar
• Ter Braake AD, Eelderink C, Zeper LW, et al. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification. Nephrol Dial Transplant. 2020;35(5):765–773. doi:10.1093/ndt/gfz190.
   PubMed Web of Science ®Google Scholar
• Zhou S-J, Wang X-X, Tang W, et al. Lower serum irisin levels are associated with increased abdominal aortic calcification in peritoneal dialysis patients. Kidney Dis (Basel). 2021;7(3):219–226. doi:10.1159/000512514.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Y, Yang P, et al. Trimethylamine-N-oxide promotes vascular calcification through activation of NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-κB (nuclear factor κB) signals. Arterioscler Thromb Vasc Biol. 2020;40(3):751–765. doi:10.1161/ATVBAHA.119.313414.
   PubMed Web of Science ®Google Scholar
• Chen T-C, Yen C-K, Lu Y-C, et al. The antagonism of 6-shogaol in high-glucose-activated NLRP3 inflammasome and consequent calcification of human artery smooth muscle cells. Cell Biosci. 2020;10(1):5. doi:10.1186/s13578-019-0372-1.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Liu H, Yu H, et al. Circular RNA Calm4 regulates hypoxia-induced pulmonary arterial smooth muscle cells pyroptosis via the Circ-Calm4/miR-124-3p/PDCD6 axis. Arterioscler Thromb Vasc Biol. 2021;41(5):1675–1693. doi:10.1161/ATVBAHA.120.315525.
   PubMed Web of Science ®Google Scholar
• Ma G, Yu Z, Nan F, et al. HCMV-IE2 promotes atherosclerosis by inhibiting vascular smooth muscle cells’ pyroptosis. Front Microbiol. 2023;14:1177391. doi:10.3389/fmicb.2023.1177391.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang Z, Wang L, et al. IL-6 promotes collagen-induced arthritis by activating the NLRP3 inflammasome through the cathepsin B/S100A9-mediated pathway. Int Immunopharmacol. 2020;88:106985. doi:10.1016/j.intimp.2020.106985.
   PubMed Web of Science ®Google Scholar
• Zhao X-K, Zhu M-M, Wang S-N, et al. Transcription factor 21 accelerates vascular calcification in mice by activating the IL-6/STAT3 signaling pathway and the interplay between VSMCs and ECs. Acta Pharmacol Sin. 2023;44(8):1625–1636. doi:10.1038/s41401-023-01077-8.
   PubMed Web of Science ®Google Scholar
• Batra G, Lakic TG, Lindbäck J, et al. Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome. JAMA Cardiol. 2021;6(12):1440–1445. doi:10.1001/jamacardio.2021.3079.
   PubMed Web of Science ®Google Scholar
• Desjardins M-P, Sidibé A, Fortier C, et al. Association of interleukin-6 with aortic stiffness in end-stage renal disease. J Am Soc Hypertens. 2018;12(1):5–13. doi:10.1016/j.jash.2017.09.013.
   PubMed Web of Science ®Google Scholar
• Gou X, Xu W, Liu Y, et al. IL-6 prevents lung macrophage death and lung inflammation injury by inhibiting GSDME-and GSDMD-mediated pyroptosis during pneumococcal pneumosepsis. Microbiol Spectr. 2022;10(2):e02049-21. doi:10.1128/spectrum.02049-21.
   PubMed Web of Science ®Google Scholar
• Ding B, Geng S, Hou X, et al. Berberine reduces renal cell pyroptosis in golden hamsters with diabetic nephropathy through the Nrf2-NLRP3-caspase-1-GSDMD pathway. Evidence-Based Complementary Altern Med. 2021;2021:1–13. doi:10.1155/2021/5545193.
   Web of Science ®Google Scholar